Antiadhesion molecule therapy in inflammatory bowel disease.
about
G Protein-Coupled Receptor 43 Modulates Neutrophil Recruitment during Acute InflammationMechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cellsLeukocyte adhesion molecules in animal models of inflammatory bowel diseaseExploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3Inflammatory bowel disease and thromboembolismVedolizumab for Crohn's disease.The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course.Anti-inflammatory Effects of Flavonoids on TNBS-induced Colitis of RatsGene transfer approaches for the treatment of inflammatory bowel disease.Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNFA randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis.CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis.The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology.Tumor necrosis factor family members and inflammatory bowel disease.Lymphocyte trafficking to inflamed skin--molecular mechanisms and implications for therapeutic target molecules.Natalizumab for the treatment of multiple sclerosis and Crohn's disease.T cell targeted immunotherapy for autoimmune disease.Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.Treatment of inflammatory bowel disease: a review of medical therapy.Lymphocyte homing and its role in the pathogenesis of IBD.Alpha4beta7/MAdCAM-1 interactions play an essential role in transitioning cryptopatches into isolated lymphoid follicles and a nonessential role in cryptopatch formation.Role of high endothelial postcapillary venules and selected adhesion molecules in periodontal diseases: a review.New and emerging treatments for ulcerative colitis: a focus on vedolizumab.Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.Integrin alpha2beta1 regulates neutrophil recruitment and inflammatory activity in experimental colitis in mice.Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis.Alpha CD 2 mAb treatment safely attenuates adoptive transfer colitis.
P2860
Q27321237-FDA4EE98-D3AC-4FC2-8C0D-680DC6417A24Q28287701-618CE94A-3FA8-46D5-B1E9-C196067541F7Q30437758-EFB1EABA-650E-4DF1-B394-81EE5467622AQ33994753-042D7095-61E9-4F4B-9691-A444E426247AQ34326640-3C90340A-719F-48A6-82BF-8452F0370B67Q34326912-A6F1651D-0C00-42AF-A531-D2D3D8717853Q34526079-9B877148-9CFE-42C7-B232-4D8D0B2DA460Q34980451-D11B37F3-B7FC-44E7-A56D-61319FF30F95Q35122162-B6A23891-9ACC-405F-81BC-80C33C2780E7Q35553478-50C36E4F-9CD9-40C0-88D9-4F76A9706572Q35596970-81D27962-7C1A-47E9-A8D7-0C778D119F9BQ35632116-89BAC6BD-1090-4B1A-B2FB-5E1EE9903D1BQ36056593-FA4F7BEA-EA49-49A5-8393-7D4F6116A71BQ36079886-48B50A9B-40C3-4E56-8C8B-A2A1CDAA1075Q36150816-17EE89B5-4AC2-498F-BD4A-3411DCF01A80Q36284072-61E2914E-B181-4441-BBEC-A5A63C31AAB5Q36359571-520596A2-6A9E-4003-B0AD-295EC8EB55E0Q36457546-B051AA93-4E1A-4D10-A6D4-99E3283E97B5Q36631424-F108DAB6-5B55-4386-8951-B24850716B8EQ37058862-03CB9A7B-CAFC-420C-A735-6828F9CC9C9DQ37130397-4CDEDF9F-39AA-47D3-B6F5-378ABEF80F24Q37423430-9DEF0001-61AC-4065-8057-54737939DE65Q38009855-E898ED8A-D0EF-4289-977D-D21D97F0C3E6Q41149278-3F4F17F3-4DBC-4EB1-9B4A-B0CDAEBCA2B1Q42024414-155FC712-5C54-43E5-A1B4-8AEB122E6D8CQ46988841-75A033A1-CAD0-40AA-84F3-3EC06F5729BCQ47927327-F969D654-EB51-49F6-98D0-C94A1F74D3FDQ52938272-C34A0C82-9A2B-427C-944E-5A1E3F5C1DEA
P2860
Antiadhesion molecule therapy in inflammatory bowel disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antiadhesion molecule therapy in inflammatory bowel disease.
@ast
Antiadhesion molecule therapy in inflammatory bowel disease.
@en
Antiadhesion molecule therapy in inflammatory bowel disease.
@nl
type
label
Antiadhesion molecule therapy in inflammatory bowel disease.
@ast
Antiadhesion molecule therapy in inflammatory bowel disease.
@en
Antiadhesion molecule therapy in inflammatory bowel disease.
@nl
prefLabel
Antiadhesion molecule therapy in inflammatory bowel disease.
@ast
Antiadhesion molecule therapy in inflammatory bowel disease.
@en
Antiadhesion molecule therapy in inflammatory bowel disease.
@nl
P2860
P1476
Antiadhesion molecule therapy in inflammatory bowel disease.
@en
P2093
Gert van Assche
P2860
P304
P356
10.1097/00054725-200207000-00009
P577
2002-07-01T00:00:00Z